1

Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, Huber C, Fauser AA, Schwerdtfeger R.

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant. 2005 May;35(10):1011-8. PMID: 15821768 [PubMed - indexed for MEDLINE]

2

Zander AR, Kroger N, Schleuning M, Finke J, Zabelina T, Beelen D, Schwerdtfeger R, Baurmann H, Bornhauser M, Ehninger G, Fauser AA, Kiehl M, Trenschel R, Ottinger HD, Bertz H, Berger J, Kolb HJ, Schaefer UW.

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML). Bone Marrow Transplant. 2003 Aug;32(4):355-61. PMID: 12900771 [PubMed - indexed for MEDLINE]

3

Schimmelpfennig C, Naumann R, Zuberbier T, Ordemann R, Baurmann H, Beyer J, Siegert W, Bornhauser M, Ehninger G.

Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2001 Apr;27(7):753-5. PMID: 11360117 [PubMed - indexed for MEDLINE]

4

Baurmann H, Nagel S, Binder T, Neubauer A, Siegert W, Huhn D.

Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood. 1998 Nov 15;92(10):3582-90. Erratum in: Blood 1999 Mar 15;93(6):2141. PMID: 9808551 [PubMed - indexed for MEDLINE]

5

Siegert W, Beyer J, Kingreen D, Blasczyk R, Baurmann H, Schwella N, Schleicher J, Kirsch A, Huhn D.

Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation. Bone Marrow Transplant. 1998 Sep;22(6):579-83. PMID: 9758347 [PubMed - indexed for MEDLINE]

6

Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D.

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol. 1994 Jun;12(6):1223-31. PMID: 7911158 [PubMed - indexed for MEDLINE]

7

Baurmann H, Cherif D, Berger R.

Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. Leukemia. 1993 Mar;7(3):384-91. PMID: 8445944 [PubMed - indexed for MEDLINE]

8

Caux F, Aractingi S, Baurmann H, Reygagne P, Dombret H, Romand S, Dubertret L

Fusarium solani cutaneous infection in a neutropenic patient. Dermatology. 1993;186(3):232-5. PMID: 8453155 [PubMed - indexed for MEDLINE]

9

Schwarz TF, Serke S, Hottentrager B, von Brunn A, Baurmann H, Kirsch A, Stolz W, Huhn D, Deinhardt F, Roggendorf M.

Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol. 1992 Feb;66(2):1273-6. PMID: 1731104 [PubMed - indexed for MEDLINE]

10

Baurmann H, Schwarz TF, Oertel J, Serke S, Roggendorf M, Huhn D.

Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Ann Hematol. 1992 Jan;64(1):43-5. PMID: 1739758 [PubMed - indexed for MEDLINE]

11

Serke S, Schwarz TF, Baurmann H, Kirsch A, Hottentrager B, Von Brunn A, Roggendorf M, Huhn D, Deinhardt F.

Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. Br J Haematol. 1991 Sep;79(1):6-13. PMID: 1654995 [PubMed - indexed for MEDLINE]

12

Schwerdtfeger R, Schmid H, Baurmann H, Kleiner S, Zeiler T, Henze G, Siegert W.

VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL. Bone Marrow Transplant. 1991;7 Suppl 2:131. PMID: 1878676 [PubMed - indexed for MEDLINE]

13

Siegert W, Josimovic-Alasevic O, Schwerdtfeger R, Baurmann H, Schmidt CA, Musch R, Schmid HJ, Hartmann R, Henze G, Huhn D, et al.

Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant. 1990 Aug;6(2):97-101. PMID: 2207458 [PubMed - indexed for MEDLINE]

Prof. Dr. med. M. Schleuning

1

Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ.

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.J Clin Oncol. 2005 Aug 20;23(24):5675-87. PMID: 16110027 [PubMed - indexed for MEDLINE]

2

Hentrich M, Oruzio D, Jager G, Schlemmer M, Schleuning M, Schiel X, Hiddemann W, Kolb HJ.

Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol. 2005 Jan;128(1):66-72. PMID: 15606551 [PubMed - indexed for MEDLINE]

3

Weisser M, Schleuning M, Ledderose G, Rolf B, Schnittger S, Schoch C, Schwerdtfeger R, Kolb HJ.

Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. Bone Marrow Transplant. 2004 Dec;34(12):1083-8. PMID: 15489879 [PubMed - in process]

4

Scheinkonig C, Kappicht S, Kolb HJ, Schleuning M.

Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant. 2004 Sep;34(6):531-6. PMID: 15286692 [PubMed - indexed for MEDLINE]

5

Schmid C, Schleuning M, Aschan J, Ringden O, Hahn J, Holler E, Hegenbart U, Niederwieser D, Dugas M, Ledderose G, Kolb HJ.

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia. 2004 Aug;18(8):1430-3. PMID: 15201854 [PubMed - indexed for MEDLINE]

6

Schleuning M, Buxbaum-Conradi H, Jager G, Kolb HJ.

Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J. 2004;5(2):135-44. PMID: 15048064 [PubMed - indexed for MEDLINE]

7

Kolb HJ, Schmid C, Chen X, Woiciechowski A, Roskrow M, Weber M, Guenther W, Ledderose G, Schleuning M.

Adoptive immunotherapy in chimeras with donor lymphocytes. Acta Haematol. 2003;110(2-3):110-20. Review. PMID: 14583671 [PubMed - indexed for MEDLINE]

8

Zander AR, Kroger N, Schleuning M, Finke J, Zabelina T, Beelen D, Schwerdtfeger R, Baurmann H, Bornhauser M, Ehninger G, Fauser AA, Kiehl M, Trenschel R, Ottinger HD, Bertz H, Berger J, Kolb HJ, Schaefer UW.

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML). Bone Marrow Transplant. 2003 Aug;32(4):355-61. PMID: 12900771 [PubMed - indexed for MEDLINE]

9

Schleuning M, Gunther W, Tischer J, Ledderose G, Kolb HJ.

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. Bone Marrow Transplant. 2003 Aug;32(3):243-50. PMID: 12858194 [PubMed - indexed for MEDLINE]

10

Kolb HJ, Guenther W, Gyurkocza B, Hoetzl F, Simoes B, Falk C, Schleuning M, Ledderose G.

Tolerance and chimerism. Transplantation. 2003 May 15;75(9 Suppl):26S-31S. Review. PMID: 12819487 [PubMed - indexed for MEDLINE]

11

Kolb HJ, Schmid Ch, Weisser M, Pihusch M, Tischer J, Pihusch R, Stoetzer O, Ledderose G, Schleuning M.

Cytoreduction, DLI, or mobilized peripheral blood progenitors. Ann Hematol. 2002;81 Suppl 2:S30-3. Review. PMID: 12611067 [PubMed - indexed for MEDLINE]

12

Schmid C, Weisser M, Ledderose G, Stotzer O, Schleuning M, Kolb HJ.

[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results] Dtsch Med Wochenschr. 2002 Oct 18;127(42):2186-92. German. PMID: 12397547 [PubMed - indexed for MEDLINE]

13

Schleuning M, Stoetzer O, Waterhouse C, Schlemmer M, Ledderose G, Kolb HJ.

Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp Hematol. 2002 Jan;30(1):7-10. PMID: 11823031 [PubMed - indexed for MEDLINE]

14

Schleuning M, Hiddemann W.

[New molecular therapy options in hematology and oncology, exemplified by STI571] Internist (Berl). 2001 Dec;42(12):1591-7. Review. German. PMID: 11793598 [PubMed - indexed for MEDLINE]

15

Stotzer OJ, Schleuning M, Ledderose G, Hiddemann W, Kolb HJ.

[Allogeneic transplantation in malignant lymphoma] Dtsch Med Wochenschr. 2001 Sep 28;126(39):1062-9. German. PMID: 11602913 [PubMed - indexed for MEDLINE]

16

Schleuning M.

Adoptive allogeneic immunotherapy--history and future perspectives. Transfus Sci. 2000 Oct;23(2):133-50. Review. PMID: 11035275 [PubMed - indexed for MEDLINE]

17

Burmeister T, Maurer J, Aivado M, Elmaagacli AH, Grunebach F, Held KR, Hess G, Hochhaus A, Hoppner W, Lentes KU, Lubbert M, Schafer KL, Schafhausen P, Schmidt CA, Schuler F, Seeger K, Seelig R, Thiede C, Viehmann S, Weber C, Wilhelm S, Christmann A, Clement JH, Ebener U, Enczmann J, Leo R, Schleuning M, Schoch R, Thiel E.

Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. Leukemia. 2000 Oct;14(10):1850-6. PMID: 11021760 [PubMed - indexed for MEDLINE]

18

Schleuning M, Jager G, Holler E, Hill W, Thomssen C, Denzlinger C, Lorenz T, Ledderose G, Wilmanns W, Kolb HJ.

Human parvovirus B19-associated disease in bone marrow transplantation. Infection. 1999 Mar-Apr;27(2):114-7. PMID: 10219641 [PubMed - indexed for MEDLINE]

19

Schleuning M, Mittermuller J, Kolb HJ.

Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients. Eur J Haematol. 1999 Mar;62(3):149-54. PMID: 10089891 [PubMed - indexed for MEDLINE]

20

Padovan CS, Yousry TA, Schleuning M, Holler E, Kolb HJ, Straube A.

Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol. 1998 May;43(5):627-33. PMID: 9585357 [PubMed - indexed for MEDLINE]

21

Bock M, Heim MU, Schleuning M, Kempter B, Mempel W.

[Previous activation of platelets during storage: possible causes] Beitr Infusionsther Transfusionsmed. 1994;32:81-3. German. PMID: 9480163 [PubMed - indexed for MEDLINE]

22

Salat C, Holler E, Schleuning M, Eisele B, Reinhardt B, Kolb H, Pihusch R, Domrath R, Hiller E.

Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol. 1995 Dec;71(6):271-4. PMID: 8534757 [PubMed - indexed for MEDLINE]

23

Bock M, Schleuning M, Heim MU, Mempel W.

Cryopreservation of human platelets with dimethyl sulfoxide: changes in biochemistry and cell function. Transfusion. 1995 Nov-Dec;35(11):921-4. PMID: 8604489 [PubMed - indexed for MEDLINE]

24

Holler E, Kolb HJ, Mittermuller J, Kaul M, Ledderose G, Duell T, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, et al.

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood. 1995 Aug 1;86(3):890-9. PMID: 7620183 [PubMed - indexed for MEDLINE]

25

Schleuning M, Brumme V, Wilmanns W.

Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):100-3. PMID: 7523957 [PubMed - indexed for MEDLINE]

26

Schleuning M, Thomssen C, Kolb HJ, Sauer HJ, Wilmanns W.

Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3. Am J Hematol. 1994 Jul;46(3):250-1. PMID: 7514849 [PubMed - indexed for MEDLINE]

27

Schleuning M, Bock M, Mempel W.

Complement activation during storage of single-donor platelet concentrates. Vox Sang. 1994;67(2):144-8. PMID: 7801603 [PubMed - indexed for MEDLINE]

28

Schleuning M, Thomssen C, Kolb HJ, Sauer H, Wilmanns W.

[61-year-old patient with hemorrhagic diathesis and fatigue] Internist (Berl). 1993 Dec;34(12):1141-5. German. PMID: 7508900 [PubMed - indexed for MEDLINE]

29

Schleuning M, Brumme V, Wilmanns W.

Growth inhibition of human leukemic cell lines by the phenothiazine derivative fluphenazine. Anticancer Res. 1993 May-Jun;13(3):599-602. PMID: 8317887 [PubMed - indexed for MEDLINE]

30

Bock M, Glaser A, Pfosser A, Schleuning M, Heim MU, Mempel W.

Storage of single-donor platelet concentrates: metabolic and functional changes. Transfusion. 1993 Apr;33(4):311-5. PMID: 8480351 [PubMed - indexed for MEDLINE]

31

Vehling-Kaiser U, Schleuning M, Kueffer G, Jauch KW, Kaiser E.

Lusorian artery lesion as rare cause of severe upper gastrointestinal tract bleeding. Dig Dis Sci. 1993 Jan;38(1):178-80. PMID: 8420753 [PubMed - indexed for MEDLINE]

32

Gerl A, Clemm C, Schleuning M, Wilmanns W.

Fatal cerebrovascular accident associated with chemotherapy for testicular cancer. Eur J Cancer. 1993;29A(8):1220-1. PMID: 7686022 [PubMed - indexed for MEDLINE]

33

Schleuning M, Utz H, Heim M, Mempel W.

Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole blood. Infusionsther Transfusionsmed. 1992 Oct;19(5):242-4. PMID: 1288768 [PubMed - indexed for MEDLINE]

34

Schleuning M, Schmid-Haslbeck M, Utz H, Jochum M, Heim M, Mempel W, Wilmanns W.

Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion. Blood. 1992 Jun 1;79(11):3071-5. PMID: 1375121 [PubMed - indexed for MEDLINE]

35

Heim MU, Bock M, Kolb HJ, Schleuning M, Mempel W.

Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang. 1992;62(3):165-8. PMID: 1319096 [PubMed - indexed for MEDLINE]

36

Schleuning M, Utz H, Heim M, Mempel W.

Decreased formation of the complement component C4A in leukocyte-depleted stored whole blood. Beitr Infusionsther. 1992;30:182-5. PMID: 1284702 [PubMed - indexed for MEDLINE]

37

Schleuning M, Munker R.

Tumor necrosis factor: an update on basic research and clinical applications. Klin Wochenschr. 1990 Sep 3;68(17):841-6. Review. PMID: 2214607 [PubMed - indexed for MEDLINE]

38

Schleuning MJ, Duggan A, Reem GH.

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes. Eur J Immunol. 1989 Aug;19(8):1491-5. PMID: 2550248 [PubMed - indexed for MEDLINE]

39

Reem GH, Duggan A, Schleuning M.

Immunoregulation and production of tumor necrosis factor alpha by human thymocytes. Cancer Res. 1989 Jul 1;49(13):3568-73. PMID: 2659163 [PubMed - indexed for MEDLINE]

40

Heim MU, Schleuning M, Eckstein R, Huhn D, Siegert W, Clemm C, Ledderose G, Kolb HJ, Wilmanns W, Mempel W.

Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation. Transfusion. 1988 May-Jun;28(3):272-5. PMID: 3130695 [PubMed - indexed for MEDLINE]

41

Schleuning M, Duggan A, Reem GH.

Cyclosporine does not inhibit the early transducing signals generated by the activation of human thymocytes. Transplant Proc. 1988 Apr;20(2 Suppl 2):63-8. PMID: 3259043 [PubMed - indexed for MEDLINE]

42

Schleuning M, Clemm C.

Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N Engl J Med. 1987 Dec 24;317(26):1666-7. PMID: 3479687 [PubMed - indexed for MEDLINE]

43

Fink M, Schleuning M, Twardzik L, Bartl R, Baumgart R, Wilmanns W.

[20-year-old patient with hemolytic anemia and leuko- and thrombopenia] Internist (Berl). 1986 Feb;27(2):131-6. German. PMID: 3514524 [PubMed - indexed for MEDLINE]

44

Schleuning M, Fink M, Weissenbacher ER, Hiller E.

[Cytostatic combination therapy in a pregnant patient with acute lymphatic leukemia] Internist (Berl). 1985 Oct;26(10):652-6. German. PMID: 3908370 [PubMed - indexed for MEDLINE]

45

Mempel W, Heim M, Eckstein R, Schleuning M, Horst S, Kettler H.

[Cryopreservation at a modern blood transfusion center] Fortschr Med. 1983 Nov 24;101(44):2050-2. German. PMID: 6654303 [PubMed - indexed for MEDLINE]

46

Fink E, Schleuning M.

Glomerular filtration of tissue kallikrein. Adv Exp Med Biol. 1983;156 (Pt B):939-47. PMID: 6344583 [PubMed - indexed for MEDLINE]

47

Fink E, Schleuning M.

Studies on the excretion of tissue kallikrein from blood into the urine. Hoppe Seylers Z Physiol Chem. 1982 Nov;363(11):1331-9. PMID: 6924633 [PubMed - indexed for MEDLINE]

PD Dr. med. R. Schwerdtfeger

1

Gorschluter M, Mey U, Glasmacher A, Schwerdtfeger R, Schmidt-Wolf IG.

Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum. Bone Marrow Transplant. 2005 Dec;36(12):1107. No abstract available. PMID: 16247438 [PubMed - in process]

2

Hess G, Bunjes D, Siegert W, Schwerdtfeger R, Ledderose G, Wassmann B, Kobbe G, Bornhauser M, Hochhaus A, Ullmann AJ, Kindler T, Haus U, Gschaidmeier H, Huber C, Fischer T.

Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study. J Clin Oncol. 2005 Oct 20;23(30):7583-93. PMID: 16234522 [PubMed - indexed for MEDLINE]

3

Ludwig B, Kraus FB, Kipp M, Preiser W, Schwerdtfeger R, Doerr HW, Buxbaum S.

Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation. J Clin Virol. 2005 Aug 17; [Epub ahead of print] PMID: 16112610 [PubMed - as supplied by publisher]

4

Dickhut A, Schwerdtfeger R, Kuklick L, Ritter M, Thiede C, Neubauer A, Brendel C.

Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Ann Hematol. 2005 Nov;84(11):722-7. Epub 2005 Aug 13. PMID: 16132912 [PubMed - in process]

5

Kroger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A, Nagler A, Binder T, Eiermann T, Madrigal A, Schwerdtfeger R, Kiehl M, Sayer HG, Beyer J, Bornhauser M, Ayuk F, Zander AR, Marks DI; Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group.

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. Br J Haematol. 2005 Jun;129(5):631-43. PMID: 15916686 [PubMed - indexed for MEDLINE]

6

Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, Huber C, Fauser AA, Schwerdtfeger R.

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant. 2005 May;35(10):1011-8. PMID: 15821768 [PubMed - indexed for MEDLINE]

7

Wassmann B, Pfeifer H, Stadler M, Bornhauser M, Bug G, Scheuring UJ, Bruck P, Stelljes M, Schwerdtfeger R, Basara N, Perz J, Bunjes D, Ledderose G, Mahlberg R, Binckebanck A, Gschaidmeier H, Hoelzer D, Ottmann OG.

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood. 2005 Jul 15;106(2):458-63. Epub 2005 Apr 7. PMID: 15817679 [PubMed - indexed for MEDLINE]

8

Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E; Acute Leukemia Working

Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004 Nov 25;351(22):2276-85. PMID: 15564544 [PubMed - indexed for MEDLINE]

9

Weisser M, Schleuning M, Ledderose G, Rolf B, Schnittger S, Schoch C, Schwerdtfeger R, Kolb HJ.

Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. Bone Marrow Transplant. 2004 Dec;34(12):1083-8. PMID: 15489879 [PubMed - in process]

10

Kroger N, Perez-Simon JA, Myint H, Klingemann H, Shimoni A, Nagler A, Martino R, Alegre A, Tomas JF, Schwerdtfeger R, Kiehl M, Fauser A, Sayer HG, Leon A, Beyer J, Zabelina T, Ayuk F, San Miguel JF, Brand R, Zander AR.

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant. 2004 Oct;10(10):698-708. PMID: 15389436 [PubMed - indexed for MEDLINE]

11

Janitschke K, Held T, Kruiger D, Schwerdtfeger R, Schlier G, Liesenfeld O.

Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clin Lab. 2003;49(5-6):239-42. PMID: 15285180 [PubMed - indexed for MEDLINE]

12

Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol. 2004 Jul 15;22(14):2816-25. PMID: 15254049 [PubMed - indexed for MEDLINE]

13

Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, Wilhelm S, Reuter S, Kern W, Sudhoff T, Morz H, Hehlmann R.

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol. 2004 Apr;125(2):196-202. PMID: 15059142 [PubMed - indexed for MEDLINE]

14

Bornhauser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G.

Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood. 2004 Apr 1;103(7):2860-1; author reply 2862. PMID: 15033884 [PubMed - indexed for MEDLINE]

15

Kroger N, Schilling G, Einsele H, Liebisch P, Shimoni A, Nagler A, Perez-Simon JA, San Miguel JF, Kiehl M, Fauser A, Schwerdtfeger R, Wandt H, Sayer HG, Myint H, Klingemann H, Zabelina T, Dierlamm J, Hinke A, Zander AR.

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. Blood. 2004 Jun 1;103(11):4056-61. Epub 2004 Feb 24. PMID: 14982868 [PubMed - indexed for MEDLINE]

16

Schetelig J, Bornhauser M, Kiehl M, Schwerdtfeger R, Kroger N, Runde V, Zabelina T, Held TK, Thiede C, Fauser AA, Beelen D, Zander A, Ehninger G, Siegert W; Cooperative German Transplant Study Group.

Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis. Bone Marrow Transplant. 2004 Mar;33(5):483-90. PMID: 14716342 [PubMed - indexed for MEDLINE]

17

Ayuk F, Shimoni A, Nagler A, Schwerdtfeger R, Kiehl M, Sayer HG, Zabelina T, Zander AR, Kroger N.

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma. Leukemia. 2004 Mar;18(3):659-62. PMID: 14671630 [PubMed - indexed for MEDLINE]

18

Wassmann B, Pfeifer H, Scheuring UJ, Binckebanck A, Gokbuget N, Atta J, Bruck P, Rieder H, Schoch C, Leimer L, Schwerdtfeger R, Ehninger G, Lipp T, Perz J, Stelljes M, Gschaidmeier H, Hoelzer D, Ottmann OG.

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib. Blood. 2004 Feb 15;103(4):1495-8. Epub 2003 Oct 23. PMID: 14576058 [PubMed - indexed for MEDLINE]

19

Zander AR, Kroger N, Schleuning M, Finke J, Zabelina T, Beelen D, Schwerdtfeger R, Baurmann H, Bornhauser M, Ehninger G, Fauser AA, Kiehl M, Trenschel R, Ottinger HD, Bertz H, Berger J, Kolb HJ, Schaefer UW.

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML). Bone Marrow Transplant. 2003 Aug;32(4):355-61. PMID: 12900771 [PubMed - indexed for MEDLINE]

20

Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Sayer HG, Kroger N, Hensel M, Scheffold C, Held TK, Hoffken K, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W; Cooperative German Transplant Study Group.

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol. 2003 Jul 15;21(14):2747-53. PMID: 12860954 [PubMed - indexed for MEDLINE]

21

Sayer HG, Kroger M, Beyer J, Kiehl M, Klein SA, Schaefer-Eckart K, Schwerdtfeger R, Siegert W, Runde V, Theuser C, Martin H, Schetelig J, Beelen DW, Fauser A, Kienast J, Hoffken K, Ehninger G, Bornhauser M; Cooperative German Transplant Study Group.

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplant. 2003 Jun;31(12):1089-95. PMID: 12796788 [PubMed - indexed for MEDLINE]

22

Ditschkowski M, Einsele H, Schwerdtfeger R, Bunjes D, Trenschel R, Beelen DW, Elmaagacli AH.

Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation. 2003 May 27;75(10):1745-7. PMID: 12777867 [PubMed - indexed for MEDLINE]

23

Kroger N, Bornhauser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schafer-Eckardt K, Beyer J, Kiehl M, Zander AR; German Cooperative Transplant Study Group.

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Ann Hematol. 2003 Jun;82(6):336-42. Epub 2003 May 1. PMID: 12728337 [PubMed - indexed for MEDLINE]

24

Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Kroger N, Hensel M, Scheffold C, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W.

Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. Ann Hematol. 2002;81 Suppl 2:S47-8. PMID: 12611075 [PubMed - indexed for MEDLINE]

25

Arnold R, Massenkeil G, Bornhauser M, Ehninger G, Beelen DW, Fauser AA, Hegenbart U, Hertenstein B, Ho AD, Knauf W, Kolb HJ, Kolbe K, Sayer HG, Schwerdtfeger R, Wandt H, Hoelzer D.

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia. 2002 Dec;16(12):2423-8. PMID: 12454748 [PubMed - indexed for MEDLINE]

26

Kroger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, Renges H, Zabelina T, Fehse B, Ayuk F, Wittkowsky G, Schmitz N, Zander AR.

Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. Blood. 2002 Dec 1;100(12):3919-24. Epub 2002 Aug 8. PMID: 12393448 [PubMed - indexed for MEDLINE]

27

Kroger N, Schwerdtfeger R, Kiehl M, Sayer HG, Renges H, Zabelina T, Fehse B, Togel F, Wittkowsky G, Kuse R, Zander AR.

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood. 2002 Aug 1;100(3):755-60. PMID: 12130482 [PubMed - indexed for MEDLINE]

28

Ottinger HD, Muller CR, Goldmann SF, Albert E, Arnold R, Beelen DW, Blasczyk R, Bunjes D, Casper J, Ebell W, Ehninger G, Eiermann T, Einsele H, Fauser A, Ferencik S, Finke J, Hertenstein B, Heyll A, Klingebiel T, Knipper A, Kremens B, Kolb HJ, Kolbe K, Lenartz E, Lindemann M, Muller CA, Mytilineos J, Niederwieser D, Runde V, Sayer H, Schaefer UW, Schmitz N, Schroder S, Schulze-Rath R, Schwerdtfeger R, Siegert W, Thiele B, Zander AR, Grosse-Wilde H.

Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol. 2001 Dec;80(12):706-14. Epub 2001 Oct 25. Review. PMID: 11797110 [PubMed - indexed for MEDLINE]

29

Bornhauser M, Kiehl M, Siegert W, Schetelig J, Hertenstein B, Martin H, Schwerdtfeger R, Sayer HG, Runde V, Kroger N, Theuser C, Ehninger G; Cooperative German Transplant Study Group.

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. Br J Haematol. 2001 Oct;115(1):119-24. PMID: 11722421 [PubMed - indexed for MEDLINE]

30

Preiser W, Brauninger S, Schwerdtfeger R, Ayliffe U, Garson JA, Brink NS, Franck S, Doerr HW, Rabenau HF.

Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol. 2001 Jan;20(1-2):59-70. Erratum in: J Clin Virol 2001 Dec;23(1-2):117. PMID: 11163584 [PubMed - indexed for MEDLINE]

31

Ordemann R, Naumann R, Geissler G, Kroschinsky F, Bornhauser M, Schwerdtfeger R, Ehninger G.

Foscarnet--an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation? Ann Hematol. 2000 Aug;79(8):432-6. PMID: 10985362 [PubMed - indexed for MEDLINE]

32

Heissig B, Pasternak G, Horner S, Schwerdtfeger R, Rossol S, Hehlmann R.

CD14+ peripheral blood mononuclear cells from chronic myeloid leukemia and normal donors are inhibitory to short- and long-term cultured colony-forming cells. Leuk Res. 2000 Mar;24(3):217-31. PMID: 10739004 [PubMed - indexed for MEDLINE]

33

Bornhauser M, Schuler U, Porksen G, Naumann R, Geissler G, Thiede C, Schwerdtfeger R, Ehninger G, Thiede HM.

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Transplantation. 1999 Feb 27;67(4):499-504. PMID: 10071016 [PubMed - indexed for MEDLINE]

34

Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE.

Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994 Nov;14(5):845-8. PMID: 7889018 [PubMed - indexed for MEDLINE]

35

Schwella N, Schwerdtfeger R, Konig V, Blasczyk R, Schmid H, Schmidt-Wolf I, Henze G, Siegert W.

Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation. Transplantation. 1994 Apr 27;57(8):1263-5. PMID: 8178353 [PubMed - indexed for MEDLINE]

36

Schwella N, Konig V, Schwerdtfeger R, Schmidt-Wolf I, Schmid H, Riess H, Siegert W.

Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant. 1994 Feb;13(2):169-71. PMID: 8205086 [PubMed - indexed for MEDLINE]

37

Schmidt CA, Oettle H, Wilborn F, Jessen J, Timm H, Schwerdtfeger R, Oertel J, Siegert W.

Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes. Bone Marrow Transplant. 1994 Jan;13(1):71-5. PMID: 8019456 [PubMed - indexed for MEDLINE]

38

Schmid H, Henze G, Schwerdtfeger R, Baumgarten E, Besserer A, Scheffler A, Serke S, Zingsem J, Siegert W.

Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone Marrow Transplant. 1993 Dec;12(6):597-602. PMID: 8136744 [PubMed - indexed for MEDLINE]

39

Schmidt-Wolf I, Schwerdtfeger R, Schwella N, Gallardo J, Schmid HJ, Huhn D, Siegert W.

Diffuse pulmonary alveolar hemorrhage after allogeneic bone marrow transplantation. Ann Hematol. 1993 Sep;67(3):139-41. PMID: 8373902 [PubMed - indexed for MEDLINE]

40

Schwella N, Schwerdtfeger R, Schmidt-Wolf I, Schmid H, Siegert W.

Pneumococcal arthritis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1993 Aug;12(2):165-6. PMID: 8401365 [PubMed - indexed for MEDLINE]

41

Beyer J, Schwerdtfeger R, Siegert W.

Graft-versus-host disease or graft-versus-host-like syndrome. Blood. 1992 Dec 1;80(11):2948-50. PMID: 1450423 [PubMed - indexed for MEDLINE]

42

Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Engelhard M, Kuse R, Tiemann M, Lennert K, Huhn D.

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med. 1992 Sep 1;117(5):364-70. PMID: 1380221 [PubMed - indexed for MEDLINE]

43

von Baeyer H, Schwerdtfeger R.

[The extracorporeal elimination of LDL cholesterol] Dtsch Med Wochenschr. 1991 Sep 27;116(39):1494. German. PMID: 1914918 [PubMed - indexed for MEDLINE]

44

Schwerdtfeger R, Hintz G, Huhn D.

Successful treatment of a patient with postpartum factor VIII inhibitor with recombinant human interferon alpha 2a. Am J Hematol. 1991 Jul;37(3):190-3. PMID: 1907095 [PubMed - indexed for MEDLINE]

45

Schwerdtfeger R, Schmid H, Baurmann H, Kleiner S, Zeiler T, Henze G, Siegert W.

VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL. Bone Marrow Transplant. 1991;7 Suppl 2:131. PMID: 1878676 [PubMed - indexed for MEDLINE]

46

Zingsem J, Zeiler T, Weisbach V, Holfeld-Ozuysal C, Zimmermann R, Heuft HG, Beyer J, Schwerdtfeger R, Eckstein R.

[Clinical use of peripheral stem cells for autologous transplantation] Beitr Infusionsther. 1991;28:251-3. German. PMID: 1725632 [PubMed - indexed for MEDLINE]

47

Siegert W, Josimovic-Alasevic O, Schwerdtfeger R, Baurmann H, Schmidt CA, Musch R, Schmid HJ, Hartmann R, Henze G, Huhn D, et al.

Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant. 1990 Aug;6(2):97-101. PMID: 2207458 [PubMed - indexed for MEDLINE]

48

Siegert W, Josimovic-Alasevic O, Schwerdtfeger R, Schmidt C, Neubauer A, Henze G, Huhn D, Diamantstein T.

Determination of soluble interleukin-2 receptors after bone marrow transplantation. Haematol Blood Transfus. 1990;33:76-7. PMID: 2323675 [PubMed - indexed for MEDLINE]

49

Siegert W, Henze G, Wagner J, Rodloff A, Zimmermann R, Malchus R, Schwerdtfeger R, Reichelt A, Graf K, Huhn D.

Invasive Trichosporon cutaneum (beigelii) infection in a patient with relapsed acute myeloid leukemia undergoing bone marrow transplantation. Transplantation. 1988 Jul;46(1):151-3. PMID: 3293275 [PubMed - indexed for MEDLINE]

50

Schwaner I, von Baeyer H, Grafenhahn H, Schwerdtfeger R, Schwartzkopff W.

[Extracorporeal lipid elimination (LDL-apheresis in the treatment of familial hypercholesterolemia: differential filtration versus dextran sulfate adsorption] Biomed Tech (Berl). 1988 Jun;33(6):130-6. German. PMID: 2462921 [PubMed - indexed for MEDLINE]

51

Schwartzkopff W, Nold A, Grafenhahn H, von Baeyer H, Schwerdtfeger R.

Efficacy of plasmapheresis, cascade-filtration and dextran-sulfate adsorption apheresis with calculation of the recovery rate of lipids and lipoproteins. Beitr Infusionsther. 1988;23:103-11. Review. PMID: 2484763 [PubMed - indexed for MEDLINE]

52

Kochinke F, Baeyer HV, Schwaner I, Schwerdtfeger R.

Comparison of plasmafractionation filters and filtration techniques in the clinical practice of LDL-apheresis. ASAIO Trans. 1986 Jul-Sep;32(1):388-91. PMID: 3778740 [PubMed - indexed for MEDLINE]

53

Kentenich H, Schwerdtfeger R, Vogel M.

[Lupus anticoagulant in pregnancy] Geburtshilfe Frauenheilkd. 1986 Jul;46(7):467-9. German. PMID: 3093309 [PubMed - indexed for MEDLINE]

54

von Baeyer H, Kochinke F, Marx M, Schwerdtfeger R, Schulten D, Kaczmarczyk G, Kessel M.

Flow controlled selective plasma ultrafiltration (SPU) with on line membrane regeneration by back flush techniques. Trans Am Soc Artif Intern Organs. 1983;29:739-43. PMID: 6673319 [PubMed - indexed for MEDLINE]

55

Hintz G, Schwerdtfeger R.

[Different proportions of factor VIII and factor VIII inhibitors in their antigen-antibody complexes] Blut. 1982 Dec;45(6):395-406. German. PMID: 6814555 [PubMed - indexed for MEDLINE]

56

Ruhl H, Fulle HH, Koeppen KM, Schwerdtfeger R.

Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia. Klin Wochenschr. 1981 Nov 2;59(21):1189-93. PMID: 6947118 [PubMed - indexed for MEDLINE